This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Semaglutide nausea is common: About 20 percent of Ozempic® ...
Drugs like Wegovy and Zepbound have been hailed as miracle treatments. But one in 10 people are what scientists call ...
Scientists are investigating whether a concentrated hop extract can trigger the gut’s “bitter brake,” a natural signaling pathway that may help reduce hunger and support appetite control.
Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...
A growing body of research shows that people who stop GLP-1 weight-loss injections such as Ozempic and Mounjaro often regain a significant portion of the weight within a year.
Over the past few years, a new class of medications has transformed the treatment of obesity. Drugs like Ozempic, Wegovy and Mounjaro work primarily by reducing appetite, helping people eat less and ...
If you're taking a GLP-1 medication for weight loss, you may have questions about managing side effects and whether to take nutritional supplements to support your health. As a pharmacist, I' ...
New York, March 11, 2026 -- Zealthy’s is pleased to announce its comprehensive telehealth platform. The new service enables physician-supervised GLP-1 weight loss programs, mental health care, ...
A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce broadly consistent weight-loss results across age, race, ethnicity, and ...
India's Health Ministry has warned pharmaceutical firms against promoting GLP-1 weight-loss drugs to the public. The CDSCO says direct or indirect advertising, including influencer campaigns, violates ...
Researchers map the peptide behind semaglutide across 25 brain regions in each sex, finding striking differences in ...
A new study suggests that a common menopause treatment may influence how effectively certain weight-loss medications work.